Medical News

RSS

Dietary MSC can help reset cell's biological clock to prevent development of breast cancer: Study

Usually when all else fails with a technical device, a "reset" button can be pressed, preventing a glitch from going any further. What if that could be done with threats to a person's health? Investigators from The Cancer Institute of New Jersey and the Environmental & Occupational Health Sciences Institute which is jointly administered by UMDNJ-Robert Wood Johnson Medical School and Rutgers, The State University of New Jersey, have discovered that a form of a dietary trace element known as selenium can help reset a cell's "biological clock" when it is disrupted by a chemical cancer-causing agent (carcinogen).

28 Apr 2010

Healthline Networks raises $14M through third round of financing led by IGC

Healthline Networks, the leading provider of intelligent health information services, today announced that it has raised $14 million in a third round of financing led by Investor Growth Capital (IGC), the wholly owned venture capital arm of Investor AB (Investor). The round also includes strategic financing from GE/NBC Universal's Peacock Equity Fund, a joint venture between GE Capital's Media, Communications & Entertainment business and NBC Universal and Reed Elsevier Ventures.

28 Apr 2010

News outlets continue malaria coverage

World Malaria Day was Sunday and news organizations continued to cover local events.

28 Apr 2010

Five-minute screening test could cut risk of developing bowel cancer: Research

A five-minute screening test could cut the risk of developing bowel cancer by a third and save thousands of lives from what is the UK's second biggest cancer killer, according to new research led by Imperial College London, published today in the Lancet.

28 Apr 2010

Laughter is truly the best medicine says new research

A new study has shown that laughter may be one of the simplest exercises that has similar effects on the body as pumping iron in the gym. Researchers have named “Laughercise” as significant elevators of mood, stress busters, immunity boosters and blood pressure and cholesterol reducers. It can also stimulate appetite for the malnourished.

28 Apr 2010

Phase Forward reports 17% increase in GAAP revenues for first-quarter 2010

Phase Forward Incorporated today announced its financial results for the first quarter of 2010.

28 Apr 2010

Ontario seniors stand against McGuinty government's $750M cuts to front-line healthcare

The Alliance of Seniors/Older Canadians Network, an organization of approximately 20 seniors organizations, representing in excess of 200,000 seniors across Ontario, along with concerned seniors from our communities, have come out today to stand against the McGuinty government's $750M cuts to front-line healthcare.

28 Apr 2010

Moody's report: States will feel pinch of reform's Medicaid, health care expansions

"The Medicaid expansion under health reform is expected to strain state budgets already distressed by the recession, despite delays for new eligibility rules and federal aid, Moody's Investors Service said in a newly released report. States that see the largest gains in Medicaid enrollment under health reform will likely see the greatest financial burden, Moody's said."

28 Apr 2010

AstraZeneca to pay $520 million in largest pharmaceutical civil settlement

AstraZeneca will pay the federal government $520 million in civil fines to settle charges of off-label marketing of the powerful antipsychotic drug Seroquel. The settlement is the largest pharmaceutical civil settlement and among the top five civil and criminal drug company settlements in U.S. history.

28 Apr 2010

PAREXEL's consolidated service revenue for third-quarter 2010 increases 10.1% to $291.2M

PAREXEL International Corporation today announced its financial results for the third quarter ended March 31, 2010.

From Parexel 28 Apr 2010

'Flexi-Scope' test reduces incidence of bowel cancer

A one-off screening test that takes just five minutes could reduce the risk of bowel cancer by one-third and save thousands of lives, UK scientists have said.

28 Apr 2010

Nile Therapeutics closes underwritten public offering of common stock

Nile Therapeutics, Inc., a company focused on the development of novel therapeutics for heart failure patients, announced the closing of its previously announced underwritten public offering of 6,500,000 units of its securities consisting of an aggregate of 6,500,000 shares of common stock and warrants to purchase an aggregate of 1,950,000 shares of common stock.

28 Apr 2010

University of Granada researcher designs reliable method to diagnose fibromyalgia

A researcher from the University of Granada has designed a reliable method that -combined with the diagnostic criteria of the American College of Reumathology- helps to diagnose fibromyalgia on the basis of patients' walk parameters, i.e. their gait.

28 Apr 2010

Doctors struggle to contact ER patients as departments bear larger patient burden

MSNBC: Doctors in ERs face significant barriers in providing the best care when phone numbers that patients give turn out to be fake or inaccurate. "It's a scenario becoming more common in emergency departments across the country, where doctors from Connecticut to Colorado say they find themselves desperately seeking patients with potentially serious or life-threatening illnesses and injuries.

28 Apr 2010

Lexicon Pharmaceuticals to present Phase 2 study results of LX1031 for non-constipating IBS at DDW 2010

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, announced today that the company will be giving poster and oral presentations on results from its Phase 2 clinical study with LX1031 in patients with non-constipating irritable bowel syndrome (IBS) at Digestive Disease Week (DDW) 2010 in New Orleans, Louisiana.

28 Apr 2010

Mesa Laboratories announces acquisition of SGM Biotech

Mesa Laboratories, Inc., a Lakewood, Colorado based manufacturer of electronic instruments and disposables, today announced the acquisition of SGM Biotech, Inc., a Montana manufacturer of biological indicator products.

28 Apr 2010

International initiative seeks to reduce heterosexual HIV transmission

Los Angeles Biomedical Research Institute has received a $350,000 grant to study the safety of a gel designed to reduce the heterosexual transmission of HIV from the International Partnership for Microbicides, a nonprofit global initiative to develop products to reduce HIV transmission, and the U.S. Agency for International Development, the Institute announced today.

28 Apr 2010

TUH, PASNAP reach tentative 4-year agreement

Temple University Hospital (TUH) and the Pennsylvania Association of Staff Nurses & Allied Professionals (PASNAP) have reached tentative 4-year contract agreements for the bargaining units that represent the Hospital's nurses and technical/professional employees, respectively.

28 Apr 2010

Phase II clinical trial to test safety and efficacy of transplanted encapsulated islets

The Juvenile Diabetes Research Foundation announced today that it is partnering with Living Cell Technologies, a New Zealand-based biotechnology company focused on developing cell based therapeutics, in a Phase II clinical trial to study the safety and effectiveness of transplanting encapsulated insulin-producing cells from pigs as a treatment for type 1 diabetes with significant hypoglycemia unawareness.

28 Apr 2010

MHS announces completion of $7.0 million Series B equity investment

Management Health Solutions, Inc. (MHS), a leading provider of supply chain management solutions to hospitals and healthcare providers across the United States, announced today the completion of a $7.0 million Series B equity investment led by Enhanced Equity Fund, L.P. (Enhanced Equity). Radius Ventures, LLC (Radius), the company's existing institutional investor, also participated in the financing round.

28 Apr 2010

Medical News

Dietary MSC can help reset cell's biological clock to prevent development of breast cancer: Study

Healthline Networks raises $14M through third round of financing led by IGC

News outlets continue malaria coverage

Five-minute screening test could cut risk of developing bowel cancer: Research

Laughter is truly the best medicine says new research

Phase Forward reports 17% increase in GAAP revenues for first-quarter 2010

Ontario seniors stand against McGuinty government's $750M cuts to front-line healthcare

Moody's report: States will feel pinch of reform's Medicaid, health care expansions

AstraZeneca to pay $520 million in largest pharmaceutical civil settlement

PAREXEL's consolidated service revenue for third-quarter 2010 increases 10.1% to $291.2M

'Flexi-Scope' test reduces incidence of bowel cancer

Nile Therapeutics closes underwritten public offering of common stock

University of Granada researcher designs reliable method to diagnose fibromyalgia

Doctors struggle to contact ER patients as departments bear larger patient burden

Lexicon Pharmaceuticals to present Phase 2 study results of LX1031 for non-constipating IBS at DDW 2010

Mesa Laboratories announces acquisition of SGM Biotech

International initiative seeks to reduce heterosexual HIV transmission

TUH, PASNAP reach tentative 4-year agreement

Phase II clinical trial to test safety and efficacy of transplanted encapsulated islets

MHS announces completion of $7.0 million Series B equity investment

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News